With a median follow-up of 8.2 (IQR, 5.6–9.7) years from diagnosis, one patient with PVs in BRCA2 experienced BC recurrence in the same breast (3.8 years after the initial diagnosis), three had contralateral BC (1.3–6.5 years after their initial BC diagnosis), and nine experienced distant recurrence (of whom 1 had also the aforementioned recurrence in the same breast). Here, BRCA2 is linked to breast cancer.